Literature DB >> 26494525

Targeting pain in Parkinson's disease.

Angelo Antonini1, Michele Tinazzi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26494525     DOI： 10.1016/S1474-4422(15)00286-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Inhibition of Spinal 5-HT3 Receptor and Spinal Dorsal Horn Neuronal Excitability Alleviates Hyperalgesia in a Rat Model of Parkinson's Disease.

Authors:  Cheng-Jie Li; Li-Ge Zhang; Lu-Bing Liu; Meng-Qi An; Li-Guo Dong; Han-Ying Gu; Yong-Ping Dai; Fen Wang; Cheng-Jie Mao; Chun-Feng Liu
Journal:  Mol Neurobiol       Date:  2022-09-27       Impact factor: 5.682

2.  Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.

Authors:  Lei-Fang Cao; Xiao-Yan Peng; Ya Huang; Bing Wang; Feng-Ming Zhou; Ruo-Xiao Cheng; Li-Hua Chen; Wei-Feng Luo; Tong Liu
Journal:  Neural Plast       Date:  2016-09-26       Impact factor: 3.599

3.  Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson's disease.

Authors:  Arturo Cuomo; Anna Crispo; Andrea Truini; Silvia Natoli; Orazio Zanetti; Paolo Barone; Marco Cascella
Journal:  J Pain Res       Date:  2019-07-22       Impact factor: 3.133

4.  Musculoskeletal Pain in Parkinson's Disease.

Authors:  Jun Li; Ben-Fan Zhu; Zhu-Qin Gu; Hui Zhang; Shan-Shan Mei; Shao-Zhen Ji; Shu-Ying Liu; Chao Han; Huai-Zhen Chen; Piu Chan
Journal:  Front Neurol       Date:  2022-01-21       Impact factor: 4.003

Review 5.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.